The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...

Actively Exploring Partnership for Alzheimer’s DevelopmentSupplementary Financing Concluded in Q4ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE ...

Keytruda (pembrolizumab) brings cancer cells out from hiding. It has been approved for treating several cancers on the NHS, ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Actively Exploring Partnership for Alzheimer's DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage bio ...

Moderna’s ( NASDAQ: MRNA) steep fall on Friday after President-elect Donald Trump selected vaccine critic Robert F. Kennedy Jr. to head the U.S. Department of Health and Human Services makes a good ...

Cancer is on the rise in America - especially among younger adults. Learn about what lifestyle choices may help to avoid early-onset cancer.

Dantech Corporation, an AWS partner since 2017, will join other industry leaders at AWS re:Invent 2024, taking place between December 2-6 at the Venetian in Las Vegas. Dantech will also be celebrating ...

Vaderis Therapeutics AG (Vaderis), a clinical stage biotechnology company focusing on treatments for rare diseases associated with vascular malformations, today announces that the US Food and Drug ...

I expect 10 companies to announce their annual increases in the second half of November. Click here for a detailed analysis.

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...